Scholars Central

Conference abstract

Development and validation of a modified Naranjo scale for better causality assessment of adverse events

Authors: Manjunath Nookala Krishnamurthy, Jyothi Sharma, Vikram Gota

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Correct causality assessment of Adverse Drug Reactions is extremely important in day-to-day medical practice. It assumes even greater significance during clinical development of a drug because of paucity of prior information available about a drugâ??s safety profile. The existing algorithms such as Naranjo scale used for causality assessments are inadequate due to improper distribution of weightage to vital questions. Therefore, a modified Naranjo scoring system for causality assessment of adverse events (AE) was developed. Methods: We modified the Naranjo scale by (a) changing the weightage given to certain responses in the existing Naranjo scores (b) expanding few questions allowing greater clarity for causality assessment (c) modifying the cut-off scores for classification of AEs as definite, probable, possible, doubtful and not related. We then validated the modified Naranjo scale against the existing scale in 19 random cases at a tertiary care cancer hospital using physicianâ??s opinion as gold standard. Results: Nineteen cases were used for validating the modified Naranjo scale. Of these, 6 cases were described by treating physician as â??unrelatedâ?? AEs and 13 as â??relatedâ?? to the drug in question. The number of cases fallen into doubtful, possible, probable and definite categories using Naranjo scale are 1, 6, 7 and 5 respectively. Using modified algorithm, number of cases fallen into not related, doubtful, possible, probable and definite categories are 1, 5, 4, 8 and 1 respectively. Categories of â??possible-definiteâ?? are considered â??relatedâ??, and â??doubtful-not relatedâ?? are considered â??unrelatedâ??. Thus, the modified algorithm had 100% concordance with physicianâ??s opinion whereas the Naranjo scale had only 73.7% concordance. Five out of 6 cases (83%) were misclassified by Naranjo as â??relatedâ?? when they were actually â??unrelatedâ??. Conclusion: The Naranjo scale showed a huge bias towards classifying AEs as â??relatedâ?? to drugs. The modified algorithm gives better sensitivity and specificity for the causality assessment of AEs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical & Experimental Pharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Pharmacology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Manjunath Nookala Krishnamurthy”
  • BylineArticles whose byline prints “Jyothi Sharma”
  • BylineArticles whose byline prints “Vikram Gota”